Cincinnati Insurance’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Cincinnati Insurance’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,240,795	Closed	-$1.41M	–	61
2025 Q1	$1.41M	Sell	1,240,795 -793,250	-39%	-$614K	0.02%	59
2024 Q4	$629K	Hold	2,034,045	–	–	0.01%	60
2024 Q3	$665K	Buy	2,034,045 +1,334,545	+191%	+$553K	0.01%	61
2024 Q2	$322K	Hold	699,500	–	–	0.01%	62
2024 Q1	$1.11M	Hold	699,500	–	–	0.02%	61
2023 Q4	$1.43M	Buy	+699,500	New	+$1.21M	0.03%	59

Other funds holding STLN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAS

TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Cincinnati Insurance's STLN Position: Q2 2025 in Review

Cincinnati Insurance sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2025, closing a stake of 1,240,795 shares — an estimated $1.41M sold.

Cincinnati Insurance first reported a position in STLN in Q4 2023 and held it in 6 quarters. The position peaked at $1.43M in Q4 2023. 79 funds tracked by Wall St. Rank hold STLN as of Q2 2025.

Cincinnati Insurance reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Cincinnati Insurance sold 1,240,795 Starling Oncology Institute, Inc. Common Stock shares in Q2 2025, an estimated $1.41M.
Cincinnati Insurance first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2023 and held it in 6 quarters.
Cincinnati Insurance's Starling Oncology Institute, Inc. Common Stock position peaked at $1.43M in Q4 2023.
79 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2025.

Based on Cincinnati Insurance's 13F filing for Q2 2025, filed 7 Aug 2025.